Last Close
102.30 $
Jul 6, 26
Market Cap
1.3 B $
Q1 2026 (TTM)
52-Week Range
%+75.7
%33.8
0.67
0.76
%-2.4
-%20.6
1M
+9.9%
3M
+7.2%
6M
+4.5%
YTD
+5.6%
1Y
+67.8%
3Y
+129.1%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
IRMD last closed at 102.30 $ (Jul 6, 26). Price data is refreshed after every trading day.
Iradimed Co trades at a trailing-twelve-month P/E of 55.76. See the comparison tables on the Peers tab for the industry context.
Iradimed Co (IRMD) has a market capitalization of approximately 1.3 B $ as of the latest reported period.
Key peers of Iradimed Co include 4DMEDICAL Ltd, Cochlear Ltd, Smith & Nephew PLC, Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi, Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.